Literature DB >> 23979628

Pathological ventricular remodeling: therapies: part 2 of 2.

Min Xie1, Jana S Burchfield, Joseph A Hill.   

Abstract

Entities:  

Keywords:  apoptosis; autophagy; cell death; fibrosis; hypertrophy; inflammation; stem cells

Mesh：

Substances：

Year:  2013        PMID： 23979628      PMCID： PMC3829603          DOI： 10.1161/CIRCULATIONAHA.113.001879

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  104 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

Review 2.  Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

Authors:  A Louis; J G Cleland; S Crabbe; S Ford; S Thackray; T Houghton; A Clark
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

3.  Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.

Authors:  Daniela Fraccarollo; Julian D Widder; Paolo Galuppo; Thomas Thum; Dimitrios Tsikas; Michael Hoffmann; Hartmut Ruetten; Georg Ertl; Johann Bauersachs
Journal:  Circulation       Date:  2008-08-04       Impact factor: 29.690

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction.

Authors:  M Hayashi; T Tsutamoto; A Wada; K Maeda; N Mabuchi; T Tsutsui; T Matsui; M Fujii; T Matsumoto; T Yamamoto; H Horie; M Ohnishi; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  Results of the Predictors of Response to CRT (PROSPECT) trial.

Authors:  Eugene S Chung; Angel R Leon; Luigi Tavazzi; Jing-Ping Sun; Petros Nihoyannopoulos; John Merlino; William T Abraham; Stefano Ghio; Christophe Leclercq; Jeroen J Bax; Cheuk-Man Yu; John Gorcsan; Martin St John Sutton; Johan De Sutter; Jaime Murillo
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

Review 7.  The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.

Authors:  Giuseppina Novo; Daniela Guttilla; Giovanni Fazio; Debbie Cooper; Salvatore Novo
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

8.  Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.

Authors:  Mihai Gheorghiade; John E A Blair; Gerasimos S Filippatos; Cezar Macarie; Witold Ruzyllo; Jerzy Korewicki; Serban I Bubenek-Turconi; Maurizio Ceracchi; Maria Bianchetti; Paolo Carminati; Dimitrios Kremastinos; Giovanni Valentini; Hani N Sabbah
Journal:  J Am Coll Cardiol       Date:  2008-04-09       Impact factor: 24.094

9.  Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).

Authors:  Christopher M O'Connor; Wendy A Gattis; Kirkwood F Adams; Vic Hasselblad; Bleakley Chandler; Aline Frey; Isaac Kobrin; Maurizio Rainisio; Monica R Shah; John Teerlink; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

10.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Authors:  Joshua M Hare; Joel E Fishman; Gary Gerstenblith; Darcy L DiFede Velazquez; Juan P Zambrano; Viky Y Suncion; Melissa Tracy; Eduard Ghersin; Peter V Johnston; Jeffrey A Brinker; Elayne Breton; Janice Davis-Sproul; Ivonne H Schulman; John Byrnes; Adam M Mendizabal; Maureen H Lowery; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Phillip Ruiz; Alexandra Amador; Jose Da Silva; Ian K McNiece; Alan W Heldman; Richard George; Albert Lardo
Journal:  JAMA       Date:  2012-12-12       Impact factor: 56.272
View more
  53 in total

1.  Left ventricular eccentricity index measured with SPECT myocardial perfusion imaging: An additional parameter of adverse cardiac remodeling.

Authors:  Alessia Gimelli; Riccardo Liga; Alberto Clemente; Gavino Marras; Annette Kusch; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2017-01-12       Impact factor: 5.952

Review 2.  Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.

Authors:  Gabriele G Schiattarella; Joseph A Hill
Journal:  Circulation       Date:  2015-04-21       Impact factor: 29.690

3.  Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.

Authors:  Khagendra Dahal; Aditya Hendrani; Sharan P Sharma; Sampath Singireddy; George Mina; Pratap Reddy; Paari Dominic; Kalgi Modi
Journal:  JAMA Intern Med       Date:  2018-07-01       Impact factor: 21.873

Review 4.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

Review 5.  Emerging therapies for right ventricular dysfunction and failure.

Authors:  Anna Klinke; Torben Schubert; Marion Müller; Ekaterina Legchenko; Jason G E Zelt; Tsukasa Shimauchi; L Christian Napp; Alexander M K Rothman; Sébastien Bonnet; Duncan J Stewart; Georg Hansmann; Volker Rudolph
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 6.  Left Ventricular Remodelling: A Problem in Search of Solutions.

Authors:  Dennis V Cokkinos; Christos Belogianneas
Journal:  Eur Cardiol       Date:  2016-08

7.  Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction.

Authors:  Eric G Schmuck; Jill M Koch; Timothy A Hacker; Charles R Hatt; Michael T Tomkowiak; Karl K Vigen; Nicholas Hendren; Cathlyn Leitzke; Ying-Qi Zhao; Zhanhai Li; John M Centanni; Derek J Hei; Denise Schwahn; Jaehyup Kim; Peiman Hematti; Amish N Raval
Journal:  J Cardiovasc Transl Res       Date:  2015-09-15       Impact factor: 4.132

Review 8.  Exercise training in adverse cardiac remodeling.

Authors:  Dirk J Duncker; Elza D van Deel; Monique C de Waard; Martine de Boer; Daphne Merkus; Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2014-02-27       Impact factor: 3.657

Review 9.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

Review 10.  Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.

Authors:  Geoffrey W Cho; Francisco Altamirano; Joseph A Hill
Journal:  Biochim Biophys Acta       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.